Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Wednesday, May 7, 2025

Abbott’s rapid blood-based concussion test is off to the races

 Ask your competent? doctor EXACTLY what this is testing for and can it be used in stroke diagnosis? Especially since young adult strokes are often misdiagnosed!

Abbott’s rapid blood-based concussion test is off to the races

Abbott’s rapid, blood-based test for concussions is making its sporting debut through the motorcycle racing series MotoAmerica, marking the first professional organization to deploy the screener at its competitions. 

The cartridge-based test for mild traumatic brain injuries—which claimed an expanded clearance from the FDA last year—runs on Abbott’s hand-held i-STAT Alinity instrument and is designed to deliver a result within 15 minutes. 

It will be kept on-hand for the on-site healthcare professionals at each U.S. event for the 2025 season, starting with this past weekend’s superbike and other races at Michelin Raceway Road Atlanta.

“This is the first ever objective test that physicians have had at the point-of-care to assist in the assessment of concussions—it changes the game,” MotoAmerica’s chief medical officer, Carl Price, said in a statement. “If a crash or fall does happen, the ability to quickly and objectively determine whether or not a rider needs a CT scan or additional evaluation, right there on-site, provides us—and our riders—with peace of mind.”

The test takes only a few drops of whole blood collected from a standard venous draw, and measures two brain-specific protein biomarkers that are released and detectable in the 24 hours following an injury. 

When it was first cleared by the FDA in 2021, the test required blood samples to be spun in a lab centrifuge. New green lights expanding its use came in 2023 and 2024, with the latter allowing the use of untreated whole blood, though the test still needs to be performed by trained medical staff.

“As both a neurologist and licensed physician, I know firsthand the limitations of relying on a subjective tool like the Glasgow Coma Scale in the assessment of brain injury,” said Beth McQuiston, a medical director in Abbott's diagnostics business. 

“The ability to objectively assess the need for a head CT scan following potential brain injury right at the point of care, whether that be at a hospital bedside or an on-site medical facility at a sporting event, means quick assessment and a quick path to the right treatment,” McQuiston added.

No comments:

Post a Comment